ASO Author Reflections: Role of SOX9 Transcription Factor in Pancreatic Neoplasms

  • Kevin Turner
  • Jennifer L. GnerlichEmail author
ASO Author Reflections



Kevin Turner and Jennifer L. Gnerlich have no conflicts of interest to disclose.


  1. 1.
    Lahat G, Lubezky N, Loewenstein S, Nizri E, Gan S, Pasmanik-Chor M, et al. Epithelial-to-Mesenchymal Transition (EMT) in Intraductal Papillary Mucinous Neoplasm (IPMN) is associated with high tumor grade and adverse outcomes. Ann Surg Oncol 2014; 21(4): 750–757.CrossRefGoogle Scholar
  2. 2.
    Meng F, Takaori K, Ito T, Masui T, Kawaguchi Y, Uemoto S. Expression of SOX9 in intraductal papillary mucinous neoplasms of the pancreas. Panceas 2014; 43(1):7–14.CrossRefGoogle Scholar
  3. 3.
    Kopp JL, von Figura G, Mayes E, et al. Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma. Cancer Cell 2012; 22(6):737–50.CrossRefGoogle Scholar
  4. 4.
    Tanaka T, Kuroki T, Adachi T, et al. Evaluation of SOX9 expression in pancreatic ductal adenocarcinoma and intraductal papillary mucinous neoplasm. Pancreas 2013; 42(3):488–93.CrossRefGoogle Scholar
  5. 5.
    Gnerlich J, Ding X, Joyce C, Turner K, Abood G, Pappas S, et al. Increased SOX9 Expression in premalignant and malignant pancreatic neoplasms. Ann Surg Oncol. Epub 24 Oct 2018.

Copyright information

© Society of Surgical Oncology 2019

Authors and Affiliations

  1. 1.Department of SurgeryUniversity of CincinnatiCincinnatiUSA
  2. 2.Department of SurgeryLouisiana State University Health Sciences CenterNew OrleansUSA

Personalised recommendations